Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma

doi:10.3748/wjg.v26.i27.3975

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8218)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

414

WORD

189

HTML

4308

Figures (1-2)

362

Tables (1-5)

257

Sum=5530

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

836

Download

1852

Sum=2688

Jul 21, 2020 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Gastroenterol. Jul 21, 2020; 26(27): 3975-3988
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3975

Open in New Tab Full Size Figure Download Figure

Figure 1 CONSORT flow diagram. TACE: Transarterial chemoembolization; HAIC: Hepatic arterial infusion chemotherapy.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan-Meier curves. A: Curves of progression-free survival; B: Curves of overall survival. Group A indicates hepatic arterial infusion chemotherapy after transarterial chemoembolization plus S-1. Group B indicates hepatic arterial infusion chemotherapy after transarterial chemoembolization. HR: Hazard ratio.

Citation: Guo JH, Liu SX, Gao S, Kou FX, Zhang X, Wu D, Li XT, Chen H, Wang XD, Liu P, Zhang PJ, Xu HF, Cao G, Zhu LZ, Yang RJ, Zhu X. Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma. World J Gastroenterol 2020; 26(27): 3975-3988
URL: https://www.wjgnet.com/1007-9327/full/v26/i27/3975.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i27.3975